Comparison of the Efficacy of Mifepristone and Marvelon Treatment for Perimenopausal Dysfunctional Uterine Bleeding

Objective: To investigate the efficacy of mifepristone and Marvelon treatment for perimenopausal dysfunctional uterine bleeding. Method: 60 patients were randomly selected from January 2016 to June 2016 in our hospital for treatment of menopausal gouthenopsis. After different treatment regimens were...

Full description

Saved in:
Bibliographic Details
Published inGeneral Surgery Vol. 1; no. 1; p. 1
Main Author Yang, Xiaopin
Format Journal Article
LanguageEnglish
Published 02.08.2017
Online AccessGet full text

Cover

More Information
Summary:Objective: To investigate the efficacy of mifepristone and Marvelon treatment for perimenopausal dysfunctional uterine bleeding. Method: 60 patients were randomly selected from January 2016 to June 2016 in our hospital for treatment of menopausal gouthenopsis. After different treatment regimens were communicated with the patients, the patients were treated with different methods. In the experimental group (28 cases), mifepristone was used to treat dysfunctional uterine bleeding. The control group (32 cases) was treated with Marvelon treatment and the results were compared between the two groups. Results: The initial conditions of the two groups were not significantly different (P > 0.05), seen from the levels of folliclein, luteinizing hormone, estrogen and progesterone. After treatment however, the effective rate of the treatment group was significantly higher than the control group (P < 0.05). Conclusion: Mifepristone is effective in the treatment of perimenopausal dysfunction. 
ISSN:2529-7732
2529-7732
DOI:10.18282/gs.v1i1.69